USD 26.73
(1.63%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 326.16 Million USD | 55.7% |
2022 | 209.48 Million USD | 39.09% |
2021 | 150.61 Million USD | -16.25% |
2020 | 179.83 Million USD | 74.53% |
2019 | 103.04 Million USD | -10.19% |
2018 | 114.73 Million USD | 343.32% |
2017 | 25.88 Million USD | 1627.7% |
2016 | 1.49 Million USD | 976.02% |
2015 | -171 Thousand USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 90.8 Million USD | -0.71% |
2024 Q1 | 91.45 Million USD | -3.35% |
2023 Q1 | 77.4 Million USD | 55.46% |
2023 Q3 | 80.31 Million USD | 8.78% |
2023 Q2 | 73.82 Million USD | -4.62% |
2023 FY | 326.16 Million USD | 55.7% |
2023 Q4 | 94.63 Million USD | 17.83% |
2022 Q3 | 58.83 Million USD | 12.37% |
2022 FY | 209.48 Million USD | 39.09% |
2022 Q1 | 48.49 Million USD | 3738.11% |
2022 Q4 | 49.78 Million USD | -15.38% |
2022 Q2 | 52.36 Million USD | 7.98% |
2021 FY | 150.61 Million USD | -16.25% |
2021 Q4 | -1.33 Million USD | -102.89% |
2021 Q1 | 55.59 Million USD | 25.53% |
2021 Q2 | 50.23 Million USD | -9.64% |
2021 Q3 | 46.11 Million USD | -8.21% |
2020 Q4 | 44.29 Million USD | -8.09% |
2020 Q3 | 48.19 Million USD | -0.35% |
2020 Q2 | 48.36 Million USD | 24.05% |
2020 FY | 179.83 Million USD | 74.53% |
2020 Q1 | 38.98 Million USD | 55.23% |
2019 Q4 | 25.11 Million USD | -4.1% |
2019 Q3 | 26.18 Million USD | -0.75% |
2019 Q2 | 26.38 Million USD | 4.08% |
2019 FY | 103.04 Million USD | -10.19% |
2019 Q1 | 25.35 Million USD | -41.99% |
2018 Q2 | 26.22 Million USD | 27.03% |
2018 Q1 | 20.64 Million USD | 112.81% |
2018 Q4 | 43.7 Million USD | 80.81% |
2018 FY | 114.73 Million USD | 343.32% |
2018 Q3 | 24.16 Million USD | -7.83% |
2017 Q4 | 9.7 Million USD | -14.89% |
2017 Q3 | 11.39 Million USD | 282.07% |
2017 Q1 | 1.8 Million USD | 60.95% |
2017 FY | 25.88 Million USD | 1627.7% |
2017 Q2 | 2.98 Million USD | 65.63% |
2016 Q4 | 1.11 Million USD | 195.25% |
2016 FY | 1.49 Million USD | 976.02% |
2016 Q3 | 379 Thousand USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2015 FY | -171 Thousand USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Embecta Corp. | 749.9 Million USD | 56.505% |
ANI Pharmaceuticals, Inc. | 305.3 Million USD | -6.835% |
Dynavax Technologies Corporation | 182.11 Million USD | -79.099% |
Esperion Therapeutics, Inc. | 73.06 Million USD | -346.397% |
Pacira BioSciences, Inc. | 490.3 Million USD | 33.477% |
PainReform Ltd. | -15 Thousand USD | 2174560.0% |
Aquestive Therapeutics, Inc. | 29.75 Million USD | -996.293% |
Sunshine Biopharma, Inc. | 8.33 Million USD | -3811.288% |
SCYNEXIS, Inc. | 124.51 Million USD | -161.947% |
China SXT Pharmaceuticals, Inc. | 553.97 Thousand USD | -58778.353% |
Cosmos Health Inc. | 4.34 Million USD | -7398.881% |
Journey Medical Corporation | 52.52 Million USD | -521.026% |
Sunshine Biopharma, Inc. | 8.33 Million USD | -3811.288% |
Safety Shot Inc | -74.45 Thousand USD | 438163.58% |
Alpha Teknova, Inc. | 10.29 Million USD | -3067.92% |
Intra-Cellular Therapies, Inc. | 430.62 Million USD | 24.257% |
Bright Green Corporation | -237.01 Thousand USD | 137714.76% |
Procaps Group, S.A. | 239.56 Million USD | -36.148% |
Theratechnologies Inc. | 62.12 Million USD | -424.987% |
Harrow Health, Inc. | 90.55 Million USD | -260.197% |
Sonoma Pharmaceuticals, Inc. | 4.74 Million USD | -6773.952% |
Biofrontera Inc. | 16.62 Million USD | -1861.683% |
DURECT Corporation | 6.83 Million USD | -4674.835% |
Supernus Pharmaceuticals, Inc. | 523.74 Million USD | 37.723% |
Cronos Group Inc. | 6.99 Million USD | -4565.625% |
OptiNose, Inc. | 62.35 Million USD | -423.092% |
Ironwood Pharmaceuticals, Inc. | 441.16 Million USD | 26.066% |
Kala Pharmaceuticals, Inc. | -303 Thousand USD | 107746.535% |
RedHill Biopharma Ltd. | 3.05 Million USD | -10579.454% |
Organogenesis Holdings Inc. | 309.79 Million USD | -5.287% |
Guardion Health Sciences, Inc. | 5.39 Million USD | -5946.306% |
Cumberland Pharmaceuticals Inc. | 33.48 Million USD | -874.049% |
Radius Health, Inc. | 307.71 Million USD | -5.998% |
Universe Pharmaceuticals INC | 10.07 Million USD | -3136.484% |
ProPhase Labs, Inc. | 16.23 Million USD | -1908.553% |
Phibro Animal Health Corporation | 312.48 Million USD | -4.378% |
Procaps Group S.A. | 239.56 Million USD | -36.148% |
Alvotech | -69.42 Million USD | 569.835% |
TherapeuticsMD, Inc. | 1.3 Million USD | -24951.382% |
Viatris Inc. | 6.43 Billion USD | 94.934% |
Rockwell Medical, Inc. | 8.7 Million USD | -3647.346% |
Aytu BioPharma, Inc. | 54.58 Million USD | -497.532% |
SIGA Technologies, Inc. | 122.09 Million USD | -167.15% |
Tilray Brands, Inc. | 223.35 Million USD | -46.034% |
Lifecore Biomedical, Inc. | 41.85 Million USD | -679.376% |
Shineco, Inc. | 882.16 Thousand USD | -36873.57% |
PetIQ, Inc. | 252.74 Million USD | -29.053% |
Regencell Bioscience Holdings Limited | -745.58 Thousand USD | 43846.546% |
Incannex Healthcare Limited | 12 Thousand USD | -2717975.0% |
Neurocrine Biosciences, Inc. | 1.84 Billion USD | 82.344% |
Alimera Sciences, Inc. | 61.17 Million USD | -433.217% |
Silver Spike Investment Corp. | 8.1 Million USD | -3925.486% |
Assertio Holdings, Inc. | 125.04 Million USD | -160.833% |
Shuttle Pharmaceuticals Holdings, Inc. | -6811.00 USD | 4788956.262% |
Petros Pharmaceuticals, Inc. | 4.19 Million USD | -7682.294% |
Clever Leaves Holdings Inc. | 6.55 Million USD | -4875.122% |
Cyclo Therapeutics, Inc. | -2.41 Million USD | 13632.995% |
Avadel Pharmaceuticals plc | 27.11 Million USD | -1102.821% |
Hempacco Co., Inc. | -1.21 Million USD | 26926.793% |
Talphera, Inc. | -4.89 Million USD | 6763.309% |
Alvotech | -69.42 Million USD | 569.835% |
Eagle Pharmaceuticals, Inc. | 221.67 Million USD | -47.139% |
Lantheus Holdings, Inc. | 709.54 Million USD | 54.031% |
Currenc Group, Inc. | 17.35 Million USD | -1779.254% |
Kamada Ltd. | 52.59 Million USD | -520.179% |
Indivior PLC | 907 Million USD | 64.039% |
Evoke Pharma, Inc. | 4.97 Million USD | -6451.221% |
Flora Growth Corp. | 17.73 Million USD | -1738.815% |
Cyclo Therapeutics, Inc. | -2.41 Million USD | 13632.995% |
Evolus, Inc. | 140.52 Million USD | -132.106% |
HUTCHMED (China) Limited | 453.55 Million USD | 28.086% |
Amphastar Pharmaceuticals, Inc. | 343.96 Million USD | 5.175% |
Akanda Corp. | 111.44 Thousand USD | -292562.115% |